Predicting seizure liability of small molecules using an in vitro multi-electrode array based assay coupled with modeling of brain disposition
{{output}}
Unintended central nervous system (CNS) effects of small molecule drugs can lead to costly attrition during drug development. CNS liability can be assessed with biochemical assays, as part of routine nonclinical toxicology studies, or via a battery of rodent C... ...
